We serve Chemical Name:ethyl 7-chloroimidazo[1,2-a]pyridine-2-carboxylate CAS:1204501-38-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:ethyl 7-chloroimidazo[1,2-a]pyridine-2-carboxylate
CAS.NO:1204501-38-1
Synonyms:ethyl 7-chloroimidazo[1,2-a]pyridine-2-carboxylate
Molecular Formula:C10H9ClN2O2
Molecular Weight:224.64400
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:43.60000
Exact Mass:224.03500
LogP:2.16440
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like ethyl 7-chloroimidazo[1,2-a]pyridine-2-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 7-chloroimidazo[1,2-a]pyridine-2-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ethyl 7-chloroimidazo[1,2-a]pyridine-2-carboxylate Use and application,ethyl 7-chloroimidazo[1,2-a]pyridine-2-carboxylate technical grade,usp/ep/jp grade.
Related News: The company forecasts that the 70-strong team will grow by around 50% in the next three years to support its clinical and commercial API manufacturing capabilities. Tetrakis(4-bromophenyl)methane manufacturers During an investor event last month, Walmsley laid out her blueprint for the new GSK. It features a 5% average sales growth rate in the next five years, leading to total sales of £33 billion ($46 billion) by 2031. 2-amino-4-arsorosophenol,hydrochloride suppliers The company forecasts that the 70-strong team will grow by around 50% in the next three years to support its clinical and commercial API manufacturing capabilities. Biphenyl-2-boronic acid pinacol ester vendor & factory Recipharm joined the COVID-19 fight in December, signing on to produce the Moderna vaccine at its plant in Monts, France. The company hasn’t revealed if the new facilities will be engaged in COVID-19 vaccine production, though the plant in Morocco will “mirror” a new fill-finish line it added in France.,The factory is part of a partnership with Nichepharm Lifesciences of India. Recipharm has an 8% stake in that company after an investment two years ago.